Effectiveness and Clinical Predictors of Virtual Group Therapy for Cannabis Use Disorder
| Journal | Drug and alcohol dependence |
| Study Type | Clinical Study |
| Population | Human participants |
Cannabis use disorder affects millions of adults, yet access to evidence-based treatment remains limited. Virtual delivery of combined CBT-MET could dramatically expand treatment availability, making this effectiveness research clinically relevant for addiction medicine practitioners.
This retrospective analysis evaluated 116 adults in a 12-week virtual group CBT-MET program for cannabis use disorder between 2020-2023. Participants showed significant reductions in cannabis use frequency, craving scores, and problematic use measures among treatment completers (≥75% attendance). The study also tracked depression and anxiety symptoms biweekly, though specific outcome data on these measures wasn’t provided in the abstract. As a retrospective analysis without a control group, the study cannot establish causation, but provides real-world effectiveness data for virtual delivery of this evidence-based intervention combination.
“Virtual group therapy for cannabis use disorder appears promising based on these completion rates and symptom improvements. However, I need randomized controlled data before recommending this as equivalent to in-person treatment for my patients with moderate to severe cannabis use disorder.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
How effective is virtual CBT-MET group therapy for cannabis use disorder?
This 12-week virtual group-based CBT-MET program demonstrated clinical efficacy for adults with cannabis use disorder. Participants who completed at least 75% of sessions showed significant improvements in cannabis use patterns, craving levels, depression, and anxiety symptoms based on validated assessment tools.
What are the advantages of delivering CBT-MET virtually for cannabis use disorder?
Virtual delivery of CBT-MET provides increased accessibility and convenience for patients with cannabis use disorder, removing geographical and transportation barriers. This study’s findings suggest that virtual group therapy can maintain therapeutic effectiveness while potentially reaching more patients who might not otherwise access in-person treatment.
What baseline factors predict better treatment outcomes in virtual CBT-MET for cannabis use disorder?
The study examined baseline predictors of treatment response using linear mixed models, though specific predictor results aren’t detailed in the summary provided. Identifying these predictors helps clinicians determine which patients are most likely to benefit from virtual CBT-MET interventions.
How long should patients engage in virtual CBT-MET therapy for optimal results?
The study used a 12-week program format and defined treatment completion as ≥75% attendance, suggesting this duration and engagement level are necessary for therapeutic benefit. Patients who met this attendance threshold showed significant improvements across multiple clinical measures including cannabis use, craving, depression, and anxiety.
Can virtual group therapy replace in-person treatment for cannabis use disorder?
This study provides evidence that virtual CBT-MET group therapy can be an effective treatment modality for cannabis use disorder, producing meaningful clinical improvements. However, treatment selection should be individualized based on patient preferences, baseline characteristics, and clinical judgment regarding the most appropriate delivery format.
